Next |
home / stock / fbrx / fbrx message board
Subject | By | Source | When |
---|---|---|---|
Huge volume today | Golden Cross | investorshub | 04/07/2023 4:04:54 AM |
Big step above 1,32 | mining101 | investorshub | 06/30/2022 5:56:55 PM |
Interesting | mining101 | investorshub | 06/27/2022 2:12:46 PM |
More | heyitsmeagain | investorshub | 04/27/2022 9:15:02 AM |
Ooooo looking for another squeeze but also, offering | heyitsmeagain | investorshub | 04/26/2022 6:18:14 PM |
Short squeeze upcoming | scotsand | investorshub | 03/23/2022 5:03:46 PM |
Support forming down here? | KeepOn | investorshub | 11/29/2021 7:40:22 PM |
$FBRX- this stock is DEAD | Nebuchadnezzar | investorshub | 09/15/2021 7:14:01 PM |
I lost more than 900k in eeenf! I | JusDePomme | investorshub | 09/14/2021 8:10:39 AM |
do you have more than $100,000 in losses? | Nebuchadnezzar | investorshub | 09/14/2021 5:22:12 AM |
LOS ANGELES, September 08, 2021--(BUSINESS WIRE)--The Schall Law | HighHoeSilverado | investorshub | 09/08/2021 3:34:36 PM |
Yet again fill my order 4.35 and take | JusDePomme | investorshub | 09/08/2021 2:41:07 PM |
In 4.35 | JusDePomme | investorshub | 09/08/2021 2:32:00 PM |
short covering alone should make this practically double soon.. | pitacorp | investorshub | 09/08/2021 1:39:36 PM |
or just pick a good entry point and | Nebuchadnezzar | investorshub | 09/07/2021 11:11:19 PM |
Afraid this go below 4 tomorrow! I hate | JusDePomme | investorshub | 09/07/2021 11:06:54 PM |
that's why I rarely day trade, maybe once | Nebuchadnezzar | investorshub | 09/07/2021 10:47:18 PM |
True, I'm just going by the 3-day rule, | pitacorp | investorshub | 09/07/2021 9:44:07 PM |
Buy 4.68 this morning sold 4.30 lost.....very hard | JusDePomme | investorshub | 09/07/2021 8:50:09 PM |
ooooops, yes, 4.15, sorry about that... I do | pitacorp | investorshub | 09/07/2021 7:09:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Forte Biosciences Inc. Company Name:
FBRX Stock Symbol:
NASDAQ Market:
Forte Biosciences Inc. Website:
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update. First Quarter 2024 Business Highlights ȁ...
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and provided a business update. 2023 Business Highlights “Forte achieved a major...